Mucolytiques
Révision par le Dr Colin Tidy, MRCGPDernière mise à jour par Dr Philippa Vincent, MRCGPDernière mise à jour 10 août 2023
Répond aux besoins du patient lignes directrices éditoriales
- TéléchargerTélécharger
- Partager
In this series:Chronic obstructive pulmonary diseaseEmphysemaSpirometryInhalers for COPDOral bronchodilatorsAcute exacerbations of COPD
Mucus (sputum) is made in the lungs. Mucolytics are medicines that make the mucus less thick and sticky and easier to cough up. They are usually prescribed for people who have a long-term (chronic) cough. They work best if taken regularly.
Dans cet article :
Poursuivre la lecture ci-dessous
What are mucolytics?
Mucolytics are medicines that make mucus less thick and sticky and easier to cough up. They are helpful where there is a long-term (chronic) cough .
The term 'expectorant' is a general term used to describe a type of cough medicine which reduces the thickness or stickiness of mucus so it can be removed from the lung more easily by coughing.
Mucolytics work by breaking down the structure of the molecules that form the mucus.
Types of mucolytics
There are a number of mucolytics available to prescribe in the UK. These include carbocisteine and erdosteine. Both are available as capsules. Carbocisteine is also available as an oral liquid.
Two other types of mucolytic are available to prescribe. They are called dornase alfa and mannitol. These medicines are inhaled but are usually only prescribed for people with cystic fibrosis.
Choix des patients pour Informations sur les médicaments

Traitement et médicaments
La résistance aux antibiotiques : une crise sanitaire cachée
If you have a bacterial infection, your doctor may prescribe antibiotics. However, unnecessary use of antibiotics can weaken their effectiveness, leading to antibiotic resistance and making future infections harder to treat. Doctors and other appropriately qualified health professionals will only prescribe antibiotics where there is a critical need.
par Victoria Raw

Traitement et médicaments
Diurétiques de l'anse
Loop diuretics are commonly used in the treatment of heart failure. In this condition, fluid accumulates in your body, due to the heart not pumping blood around the body as well as it normally would. So, you may become breathless (as fluid accumulates in the lungs) and your ankles and legs may swell with extra fluid in the tissues (oedema). Loop diuretics are also used to treat other conditions which cause fluid to build up in the body, such as certain liver and kidney disorders. They are also sometimes used to treat high blood pressure (hypertension). However, generally, a different type of diuretic called a thiazide diuretic is more commonly used to treat high blood pressure. There are different types of diuretics. Loop diuretics are one type. They include furosemide, bumetanide and torasemide. Each comes in different brand names.
par le Dr Colin Tidy, MRCGP
Poursuivre la lecture ci-dessous
How do mucolytics work?
The mucus (sputum) in the lungs is held together by certain bonds. Mucolytics work by breaking these bonds. When these bonds are broken, the mucus becomes less sticky and less thick and is therefore easier to cough up. This may also result in making it harder for germs (bacteria) to infect the mucus and cause chest infections.
When are mucolytics prescribed?
They are normally prescribed for people with a long-term (chronic) productive cough. People with a productive cough make a lot of mucus (sputum) in their lungs . Examples of people who may have a chronic productive cough include people with chronic obstructive pulmonary disease (COPD) and people with cystic fibrosis.
They are most likely to help in people with moderate or severe COPD who have frequent or significant flare-ups (exacerbations). The number of flare-ups of symptoms tends to be less in people who take a mucolytic.
Dornase alfa is usually only prescribed for people with cystic fibrosis who have a reduced lung capacity. It helps to make it easier to cough up thick mucus and is thought to improve how well the lungs work. It also limits any further damage to the lungs. This medicine is usually started by a doctor who specialises in treating patients with cystic fibrosis. Mannitol is an alternative for people with cystic fibrosis who can't take dornase alpha.
Poursuivre la lecture ci-dessous
How to take mucolytics
Mucolytics work best when they are taken regularly.
Carbocisteine and erdosteine are usually taken twice a day (but up to four times a day) by adults. These medicines may be stopped if they have been taken for one month and don't seem to be helping symptoms. Children may need to take these medicines three or four times a day.
Dornase alfa is taken by breathing it directly into the lungs once or twice a day, using a machine called a nebuliser. Mannitol is taken by breathing it in from a hand-held inhaler.
Mucolytics side-effects
Side-effects of treatment with mucolytics occur rarely but some people have reported bleeding from the gut (gastrointestinal tract). . Black tarry stools are a sign of bleeding from the gut - although this is a very rare side effect, people who develop this should stop their carbocisteine or erdosteine and seek medical advice
Who cannot have mucolytics?
Most people are able to take a mucolytic; however, they should not be used in people who have a stomach ulcer.
Can you buy mucolytics?
No, they require a prescription.
What else can help a cough?
Medical advice should be sought for a cough that has persisted without improving for more than three weeks. Treatment will depend on the cause.
Some people need help with a long-term cough for which no cause can be found. A steamy shower or steam from a humidifier can help to loosen phlegm. Simple linctus and cough sweets can be soothing.
Cough suppressant medicines may help, especially for a night-time cough, but these usually contain codeine which can cause constipation if taken excessively.
For more information, see the separate leaflet called Chronic Persistent Cough in Adults.
Autres lectures et références
- British National Formulary (BNF)NICE Evidence Services (accès au Royaume-Uni uniquement)
- Poudre sèche de mannitol pour inhalation pour le traitement de la fibrose kystiqueNICE Technology Appraisal Guidance, novembre 2012
- Maladie pulmonaire obstructive chroniqueNICE Guidance (décembre 2018 - dernière mise à jour 2019)
- Maladie pulmonaire obstructive chroniqueNICE CKS, juin 2023 (accès au Royaume-Uni uniquement)
- Effets de la carbocistéine sur les patients atteints de BPCOJournal international de la BPCO
Historique de l'article
Les informations contenues dans cette page sont rédigées et évaluées par des cliniciens qualifiés.
Prochaine révision prévue : 8 août 2028
10 Aug 2023 | Dernière version

Demandez, partagez, connectez-vous.
Parcourez les discussions, posez des questions et partagez vos expériences sur des centaines de sujets liés à la santé.

Vous ne vous sentez pas bien ?
Évaluez gratuitement vos symptômes en ligne